A randomized study of melphalan 200 mg/m2 vs 280 mg/m2 as a preparative regimen for patients with multiple myeloma undergoing auto-SCT - Concepedia

Concepedia

Publication | Open Access

A randomized study of melphalan 200 mg/m2 vs 280 mg/m2 as a preparative regimen for patients with multiple myeloma undergoing auto-SCT

DOI Full Paper Access

30

Citations

25

References

2015

Year

Pamela S. Becker, Ted Gooley, Thomas R. Chauncey, DG Maloney, Ajay K. Gopal, D J Green, Oliver W. Press, Michael Lill, J.J. Ifthikharuddin, Robert Vescio,

Bone Marrow Transplantation

Hematological MalignancyMelphalan 200Randomized StudyMedicineHematologyImmunologyMyeloid NeoplasiaMultiple MyelomaOncologyRadiation OncologyHealth Sciences

References

	Year	Citations

Page 1

Page 1